DD213216A5 - Verfahren zur herstellung eines neuen pynolidin-derivates - Google Patents

Verfahren zur herstellung eines neuen pynolidin-derivates Download PDF

Info

Publication number
DD213216A5
DD213216A5 DD83257518A DD25751883A DD213216A5 DD 213216 A5 DD213216 A5 DD 213216A5 DD 83257518 A DD83257518 A DD 83257518A DD 25751883 A DD25751883 A DD 25751883A DD 213216 A5 DD213216 A5 DD 213216A5
Authority
DD
German Democratic Republic
Prior art keywords
temperature
product
alkyl
general formula
radical
Prior art date
Application number
DD83257518A
Other languages
German (de)
English (en)
Inventor
Jean-Louis Fabre
Daniel Farge
Claude James
Daniel Lave
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of DD213216A5 publication Critical patent/DD213216A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DD83257518A 1982-12-07 1983-12-05 Verfahren zur herstellung eines neuen pynolidin-derivates DD213216A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8220492A FR2537133A1 (fr) 1982-12-07 1982-12-07 Nouveaux derives de la (piperazinyl-1)-5 pyrrolidine, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
DD213216A5 true DD213216A5 (de) 1984-09-05

Family

ID=9279863

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83257518A DD213216A5 (de) 1982-12-07 1983-12-05 Verfahren zur herstellung eines neuen pynolidin-derivates

Country Status (25)

Country Link
US (1) US4547504A (xx)
EP (1) EP0110795B1 (xx)
JP (1) JPS59110670A (xx)
AT (1) ATE18548T1 (xx)
AU (1) AU560075B2 (xx)
BG (1) BG40808A3 (xx)
CA (1) CA1208645A (xx)
CS (1) CS240982B2 (xx)
DD (1) DD213216A5 (xx)
DE (1) DE3362566D1 (xx)
DK (1) DK562783A (xx)
ES (1) ES8406436A1 (xx)
FI (1) FI76320C (xx)
FR (1) FR2537133A1 (xx)
GR (1) GR72855B (xx)
HU (1) HU191903B (xx)
IE (1) IE56453B1 (xx)
IL (1) IL70396A (xx)
MA (1) MA19966A1 (xx)
NO (1) NO158218C (xx)
NZ (1) NZ206498A (xx)
PL (1) PL141385B1 (xx)
PT (1) PT77774B (xx)
SU (1) SU1240359A3 (xx)
ZA (1) ZA839070B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1279645C (en) * 1986-02-27 1991-01-29 Ineke Van Wijngaarden Aryl-substituted (n-piperidinyl)methyl- and (n-piperazinyl)methylazoles having antipsychotic properties
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
US6897213B1 (en) 1995-11-21 2005-05-24 Warner-Lambert Company Heterocycles as cholecystokinin (CCK) ligands
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247549A (en) * 1978-12-27 1981-01-27 Ici Americas Inc. Piperazine-1-carboxylic acid esters possessing antidepressant or analgesic activity

Also Published As

Publication number Publication date
IE832867L (en) 1984-06-07
NO158218C (no) 1988-08-03
DK562783A (da) 1984-06-08
CA1208645A (fr) 1986-07-29
GR72855B (xx) 1983-12-08
AU2210883A (en) 1984-06-14
IL70396A0 (en) 1984-03-30
ES527897A0 (es) 1984-08-01
PL141385B1 (en) 1987-07-31
NZ206498A (en) 1986-05-09
IL70396A (en) 1986-11-30
SU1240359A3 (ru) 1986-06-23
DK562783D0 (da) 1983-12-06
CS240982B2 (en) 1986-03-13
IE56453B1 (en) 1991-08-14
FI76320C (fi) 1988-10-10
ZA839070B (en) 1984-07-25
PT77774B (fr) 1986-07-11
FI76320B (fi) 1988-06-30
PT77774A (fr) 1984-01-01
BG40808A3 (en) 1987-02-16
NO834481L (no) 1984-06-08
FI834453A0 (fi) 1983-12-05
CS904183A2 (en) 1985-06-13
EP0110795A1 (fr) 1984-06-13
DE3362566D1 (en) 1986-04-17
FR2537133A1 (fr) 1984-06-08
HU191903B (en) 1987-04-28
FI834453A (fi) 1984-06-08
ATE18548T1 (de) 1986-03-15
NO158218B (no) 1988-04-25
PL244921A1 (en) 1985-03-26
FR2537133B1 (xx) 1985-05-17
JPS59110670A (ja) 1984-06-26
ES8406436A1 (es) 1984-08-01
US4547504A (en) 1985-10-15
AU560075B2 (en) 1987-03-26
MA19966A1 (fr) 1984-07-01
EP0110795B1 (fr) 1986-03-12

Similar Documents

Publication Publication Date Title
DE3687288T2 (de) Chinuclidinderivate.
DE69722858T2 (de) Intimale verdickungsinhibitoren
DD211351A5 (de) Verfahren zur herstellung von neuen thieno-(3,2-c)pyridin-derivaten
DE60307875T2 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusamensetzungen
DD263772A5 (de) Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
EP0192056B1 (de) Verfahren zur Herstellung von Labdan-Derivaten und ihre Verwendung als Arzneimittel
CH637956A5 (de) In 11-stellung substituierte 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
EP0089028B1 (de) Neue Theophyllin-Derivate und Verfahren zu ihrer Herstellung
DD297822A5 (de) Neue 1h, 3h-pyrrol(1,2-c)thiazolcarboxamid-7-derivate, ihre herstellung und sie enthaltende pharmazeutische verbindungen
DD240205A5 (de) Substituierte benzylphthalazinon-derivate
DE4430091A1 (de) Verwendung von N-substituierten Phenothiazinen
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0152868B1 (de) Isoxazol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD213216A5 (de) Verfahren zur herstellung eines neuen pynolidin-derivates
DD210051A5 (de) Verfahren zur darstellung eines neuen thienopyridinon-derivats
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
DE3804936A1 (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2734270C2 (xx)
CH630058A5 (de) Verfahren zur herstellung von neuen disubstituierten phenolaethern des 3-amino-2-hydroxypropans.
EP0086453A2 (de) Thiazaspiranderivate, Verfahren zu ihrer Herstellung und Arzneimittel
DD150061A5 (de) Verfahren zur herstellung von neuen benzo-as-triazin-derivaten
DE2656678C2 (de) 4-Amino-trans-decahydrochinolin-Derivate und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
DE2410201B2 (de) 6-substituierte 3-carbaethoxyhydrazinopyridazine beziehungsweise ihre salze sowie solche enthaltende arzneimittel und verfahren zur herstellung derselben